{ "cik": 1850902, "cik_padded": "0001850902", "entityName": "Alpha Teknova, Inc.", "fiscal_years": [ { "accn": "0001850902-26-000002", "filed": "2026-03-02", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1148000.0, "cash": 5912000.0, "cost_of_revenue": 27079000.0, "eps_diluted": -0.32, "free_cash_flow": -9794000.0, "gross_profit": 13441000.0, "net_income": -17259000.0, "operating_cash_flow": -8646000.0, "operating_income": -16976000.0, "revenue": 40520000.0, "stockholders_equity": 68775000.0, "total_assets": 103584000.0, "total_liabilities": 34809000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.3317127344521224, "leverage": 0.5061286804798255, "net_margin": -0.42593780848963475, "operating_margin": -0.4189536031589338, "revenue_growth_yoy": 0.07351967147966618, "roa_avg2y": -0.1552396414709943, "roa_period_end": -0.1666183966635774, "roe_avg2y": -0.22834046663006305, "roe_period_end": -0.250948745910578 } }, { "accn": "0001850902-26-000002", "filed": "2026-03-02", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1125000.0, "cash": 3708000.0, "cost_of_revenue": 30514000.0, "eps_diluted": -0.57, "free_cash_flow": -13516000.0, "gross_profit": 7231000.0, "net_income": -26745000.0, "operating_cash_flow": -12391000.0, "operating_income": -26146000.0, "revenue": 37745000.0, "stockholders_equity": 82394000.0, "total_assets": 118769000.0, "total_liabilities": 36375000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.19157504305205988, "leverage": 0.4414763210913416, "net_margin": -0.708570671612134, "operating_margin": -0.6927010200026493, "revenue_growth_yoy": 0.028922691091484026, "roa_avg2y": -0.21624702857420075, "roa_period_end": -0.22518502302789448, "roe_avg2y": -0.31021283999304067, "roe_period_end": -0.3245988785591184 } }, { "accn": "0001850902-26-000002", "filed": "2026-03-02", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 7934000.0, "cash": 28484000.0, "cost_of_revenue": 26388000.0, "eps_diluted": -1.16, "free_cash_flow": -26748000.0, "gross_profit": 10296000.0, "net_income": -36780000.0, "operating_cash_flow": -18814000.0, "operating_income": -35563000.0, "revenue": 36684000.0, "stockholders_equity": 90036000.0, "total_assets": 128587000.0, "total_liabilities": 38551000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.2806673209028459, "leverage": 0.4281731751743747, "net_margin": -1.0026169447170428, "operating_margin": -0.9694417184603643, "revenue_growth_yoy": -0.11434089811685176, "roa_avg2y": -0.26192103913860876, "roa_period_end": -0.2860320250103043, "roe_avg2y": -0.3873189378741687, "roe_period_end": -0.40850326536052245 } }, { "accn": "0000950170-25-035705", "filed": "2025-03-07", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 28149000.0, "cash": 42236000.0, "cost_of_revenue": 23944000.0, "eps_diluted": -1.69, "free_cash_flow": -55549000.0, "gross_profit": 17476000.0, "net_income": -47468000.0, "operating_cash_flow": -27400000.0, "operating_income": -49659000.0, "revenue": 41420000.0, "stockholders_equity": 99885000.0, "total_assets": 152261000.0, "total_liabilities": 52376000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.4219217769193626, "leverage": 0.5243630174700906, "net_margin": -1.1460164171897633, "operating_margin": -1.198913568324481, "revenue_growth_yoy": 0.12270620442902448, "roa_avg2y": -0.297817876099532, "roa_period_end": -0.31175415897701975, "roe_avg2y": -0.3905416968340683, "roe_period_end": -0.4752265104870601 } }, { "accn": "0000950170-24-036624", "filed": "2024-03-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 19877000.0, "cash": 87518000.0, "cost_of_revenue": 19272000.0, "eps_diluted": -0.61, "free_cash_flow": -28946000.0, "gross_profit": 17621000.0, "net_income": -9803000.0, "operating_cash_flow": -9069000.0, "operating_income": -12008000.0, "revenue": 36893000.0, "stockholders_equity": 143203000.0, "total_assets": 166511000.0, "total_liabilities": 23308000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.4776244816089773, "leverage": 0.162761953311034, "net_margin": -0.2657143631583227, "operating_margin": -0.32548179871520344, "revenue_growth_yoy": 0.17880308016742819, "roa_avg2y": -0.08545823852987072, "roa_period_end": -0.05887298737020377, "roe_avg2y": -0.12256048009001688, "roe_period_end": -0.06845526979183397 } }, { "accn": "0000950170-23-010926", "filed": "2023-03-30", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5466000.0, "cash": 3315000.0, "cost_of_revenue": 13542000.0, "eps_diluted": 0.16, "free_cash_flow": -2961000.0, "gross_profit": 17755000.0, "net_income": 3570000.0, "operating_cash_flow": 2505000.0, "operating_income": 4663000.0, "revenue": 31297000.0, "stockholders_equity": 16767000.0, "total_assets": 62911000.0, "total_liabilities": 10506000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5673067706169921, "leverage": 0.6265879405976025, "net_margin": 0.11406844106463879, "operating_margin": 0.14899191615809823, "roa_period_end": 0.05674683282732749, "roe_avg2y": 0.24059035616807628, "roe_period_end": 0.21291823224190373 } }, { "accn": "0000950170-22-004176", "filed": "2022-03-18", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "stockholders_equity": "USD" }, "fundamentals": { "cash": 4144000.0, "stockholders_equity": 12910000.0 }, "period_end": "2019-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001850902-26-000002", "filed": "2026-03-02", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2835", "sic_description": "In Vitro & In Vivo Diagnostic Substances", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001850902.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001850902.json" }, "ticker": "TKNO" }